Bavarian Nordic

News

Bavarian Nordic urges investors to accept takeover offer

A private equity investment consortium has raised a takeover offer for Denmark's Bavarian Nordic, but some shareholders are still reluctant to sell.

News

France probes side effects with Valneva's chikungunya jab

France's national public health agency has halted dosing of Valneva's chikungunya vaccine in older people while it investigates a safety signal.

News

Bavarian Nordic chikungunya vaccine gets FDA okay

There are now two vaccines to protect against chikungunya approved for use in the US, after Bavarian Nordic gets the green light for Vimkunya.

News

CHMP backs Bavarian Nordic's chikungunya jab

Bavarian Nordic is likely just weeks away from bringing the second chikungunya vaccine to the EU, and the first approved for use in adolescents.

News

Colourised transmission electron micrograph of mpox virus particles

NIH study backs Bavarian Nordic mpox jab for adolescents

An independent study has found that Bavarian Nordic's mpox vaccine Jynneos – currently only authorised for use in adults in the US – is also safe and generates a strong antibody response in

News

Expert says supplies of mpox vaccine unlikely to suffice

Emergent BioSolutions, one of only three companies with a vaccine for mpox, has agreed to donate 50,000 doses of its shot for use in the current outbreak concentrated in central Africa, but

Bavarian Nordic urges investors to accept takeover offer

France probes side effects with Valneva's chikungunya jab

Bavarian Nordic chikungunya vaccine gets FDA okay

CHMP backs Bavarian Nordic's chikungunya jab

NIH study backs Bavarian Nordic mpox jab for adolescents

Expert says supplies of mpox vaccine unlikely to suffice

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Bavarian Nordic

Editor's Picks